A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia

Diagnostic Microbiology and Infectious Disease

Volumn 36, Issue 3, 2000, Pages 145-158

  Bhavnani, Sujata M ^a   Drake, Julie A ^a   Forrest, Alan ^a   Deinhart, June A ^a   Jones, Ronald N ^b   Biedenbach, Douglas J ^b   Ballow, Charles H ^a  

^a MILLARD FILLMORE HOSPITAL   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Bacteremia; Classification and regression tree analysis; Enterococcus; Nosocomial pathogens; Resistance

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; CASE CONTROL STUDY; CLASSIFICATION; ENTEROCOCCUS; FEMALE; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; APACHE; BACTEREMIA; CASE-CONTROL STUDIES; CROSS INFECTION; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MEDICAL RECORDS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; TREATMENT OUTCOME; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 0034114065     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(99)00136-4     Document Type: Article

References (45)

1. Boyle J.F., Soumakis S.A., Rendo A., Herrington J.A., Gianarkis D.G., Thurgerg B.E., Painter B.G. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol. 31:1993;1280-1285.
2. Bryan C.S., Reynolds K.L., Brown J.J. Mortality associated with enterococcal bacteremia. Surg Gynecol Obstet. 160:1985;557-561.
3. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR. 42:1993;597-599.
4. Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. MMWR. 46:1997;765-766.
5. Update Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997 . MMWR. 46:1997;813-815.
6. Curbelo, D. E., Koll, B. S., Wilets, I., & Raucher B. (1997). Risk factors for the acquisition of vancomycin resistant enterococcus (VRE) in 202 patients with enterococcal bacteremia. In: 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology (abstr J38).
7. Edmond M.B., Ober J.F., Dawson J.D., Weinbaum D.L., Wenzel P.R. Vancomycin-resistant enterococcal bacteremia natural history and attributable mortality . Clin Infect Dis. 23:1996;1234-1239.
8. Edmond, M. B., Wallace, S. E., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1996) Surveillance at 49 U.S. medical centers for vancomycin-resistant enterococcal (VRE) bacteremia. In: 34th Annual Meeting of the Infectious Diseases Society of America, New Orleans, LA, Alexandra, VA: Infectious Diseases Society of America (abstr 49).
9. Edmond M.B., Ober J.F., Weinbaum D.L., Pfaller M.A., Hwang T., Sanford M.D., Wenzel R.P. Vancomycin-resistant Enterococcus faecium bacteremia risk factors for infection . Clin Infect Dis. 20:1995;1126-1133.
10. Emori T.G., Gaynes R.P. An overview of nosocomial infections including the role of the microbiology laboratory. Clin Microbiol Rev. 6:1993;428-442.
11. Handwerger S., Raucher B., Altarac D., Monka J., Marchione S., Singh K.V., Murray B.E., Wolff J., Walters B. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 16:1993;750-755.
12. Hiramatsu K., Hanaki H., Ino T., Yabuta K., Oguri T., Tenover F.C. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother. 40:1997;135-136.
13. Jones R.N., Marshall S.A., Pfaller M.A., Wilke W.W., Hollis R.J., Erwin M.E., Edmond M.B., Wenzel R.P. Nosocomial enterococcal blood stream infections in the SCOPE Program antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy . Diagn Microbiol Infect Dis. 29:1997;95-102.
14. Jordens J.Z., Bates J., Griffiths D.T. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother. 34:1994;515-528.
15. Karanfil L.V., Murphy M., Josephson A., Gaynes R., Mandel L., Hill B.C., Swenson J.M. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol. 13:1992;195-200.
16. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II a severity of disease classification system . Crit Care Med. 13:1985;818-829.
17. Lam S., Singer C., Tucci V., Morthland V.H., Pfaller M.A., Isenberg H.D. The challenge of vancomycin-resistant enterococci a clinical and epidemiologic study . Am J Infect Control. 23:1995;170-180.
18. Leclercq R., Derlot E., Duval J., Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 319:1988;157-161.
19. Linden P.K., Pasculle A.W., Manez R., Kramer D.J., Fung J.J., Pinna A.D., Kusne S. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis. 22:1996;663-670.
20. Livornese L.L. Jr, Dias S., Samel C., Romanowski B., Taylor S., May P., Pitsakis P., Woods G., Kaye D., Levison M.E., Johnson C.C. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med. 117:1992;112-116.
21. Luber A.D., Jacobs R.A., Jordan M., Guglielmo B.G. Relative importance of oral versus intravenous vancomycin exposure in the development of vancomycin-resistant enterococci. J Infect Dis. 173:1996;1292-1293.
22. Lucas G.M., Lechtzin N., Puryear D.W., Yau L.L., Flexner C.W., Moore R.D. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia Comparisons of clinical features and outcomes . Clin Infect Dis. 26:1998;1127-1133.
23. Montecalvo M.A., Shay D.K., Patel P., Tacsa L., Maloney S.A., Jarvis W.R., Wormser G.P. Bloodstream infections with vancomycin-resistant enterococci. Arch Intern Med. 156:1996;1458-1462.
24. Mainous M.R., Lipsett P.A., O'Brien M. Enterococcal bacteremia in the surgical intensive care unit Does vancomycin resistance affect mortality? Arch Surg. 132:1997;76-81.
25. Moreno F., Grota P., Crisp C., Magnon K., Melcher G.P., Jorgensen J.H., Patterson J.E. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis. 21:1995;1234-1237.
26. Morris J.G. Jr, Shay D.K., Hebden J.N., McCarter R.J. Jr, Perdue B.E., Jarvis W., Johnson J.A., Dowling T.C., Polish L.B., Schwalbe R.S. Enterococci resistant to multiple antimicrobial agents, including vancomycin establishment of endemicity in a university medical center . Ann Intern Med. 123:1995;250-259.
27. Approval standard M7-A4. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 1997;NCCLS, Villanova, PA.
28. th Information Supplement M100-S9. 1999;NCCLS, Villanova, PA.
29. Newell K.A., Millis J.M., Arnow P.M., Bruce D.S., Woodle E.S., Cronin D.C., Loss G.E., Grewal H., Lissoos T., Schiano T., Mead J., Thistlethwaite J.R. Jr. Incidence and outcome of infection by vancomycin-resistant enterococcus following orthotopic liver transplantation. Transplantation. 65:1998;439-442.
30. Papanicolaou G.A., Meyers B.R., Meyers J., Mendelson M.H., Lou W., Emre S., Sheiner P., Miller C. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients risk factors for acquisition and mortality . Clin Infect Dis. 23:1996;760-766.
31. Pegues, D. A., Pegues, C. F., & Hooper, D. C. (1996). Emergence of a highly resistant strain of vanA Enterococcus faecium at a large teaching hospital. In: 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC: American Society for Microbiology (Abstr J1).
32. Pfaller M.A., Wendt C., Hollis R.J., Wenzel R.P., Fritschel S.J., Neubauer J.J., Herwaldt L.A. Comparative evaluation of an automated ribotyping system versus pulsed-field gel electrophoresis for epidemiological typing of clinical isolates of Escherichia coli and Pseudomonas aeruginosa from patients with recurrent Gram-negative bacteremia. Diagn Microbiol Infect Dis. 25:1996;1-8.
33. Pfaller M.A., Jones R.N., Doern G.V., Kugler K. Bacterial pathogens isolated from patients with bloodstream infection frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997) . Antimicrob Agents Chemother. 42:1998;1762-1770.
34. Rubin L.G., Tucci V., Cercenado E., Eliopoulos G., Isenberg H.D. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol. 13:1992;700-705.
35. Schwalbe R.S., Stapleton J.T., Gilligan P.H. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med. 316:1987;927-931.
36. Shay D.K., Maloney S.A., Montecalvo M., Banerjee S., Wormser G.P., Arduino M.J., Bland L.A., Jarvis W.R. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis. 172:1995;993-1000.
37. Slaughter S., Hayden M.K., Nathan C., Hu Tzyy-Chyn, Rice T., Van Voorhis J., Matushek M., Franklin C., Weinstein R.A. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med. 125:1996;448-456.
38. Stosor V., Peterson L.R., Postelnick M., Noskin G.A. Enterococcus faecium bacteremia does vancomycin resistance make a difference? Arch Intern Med. 158:1998;522-527.
39. Stroud L., Edwards J., Danzig L., Culver D., Gaynes R. Risk factors for mortality associated with enterococcal bloodstream Infections. Infect Control Hosp Epidemiol. 17:1996;576-580.
40. Tornieporth N.G., Roberts R.B., John J., Hafner A., Riley L.W. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis. 23:1996;767-772.
41. Uttley A.H.C., Collins C.H., Naidoo J., George R.C. Vancomycin-resistant enterococci. Lancet. 1:1988;57-58.
42. Uttley A.C.H., George R.C., Naidoo J., Woodford N., Johnson A.P., Collins C.H., Morrison D., Gilfillan A.J., Fitch L.E., Heptonstall J. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect. 103:1989;173-181.
43. Wiedemann, B. & Grimm, H. Susceptibility to antibiotics: species, incidence and trends. In: Antibiotics in Laboratory Medicine, 4th edition V Lorian (Ed). Baltimore, Maryland: Williams and Wilkins, pp 1156-1157.
44. Wilke W.W., Marshall S.A., Coffman S.L., Pfaller M.A., Edmond M.B., Wenzel R.P., Jones R.N. Vancomycin-resistant Enterococcus raffinosus: molecular epidemiology, species, identification error, and frequency of occurrence in a national surveillance program (SCOPE). Diagn Microbiol Infect Dis. 28:1997;43-49.
45. th Interscience Conference on Antimicrobial Agents and Chemotherapy. October 20-23, Atlanta, GA. American Society for Microbiology, Abstr 258.